Cutaneous Oncology News

Outpatient dermatology consultation changed the diagnosis and the management of disease in children with cancer, affecting their care, according to recently published study results in the Journal of the American Academy of Dermatology.

Renal transplant recipients had a greater risk than the general population for melanoma, according to recently published study results in JAMA Dermatology.

Non-Hispanic white patients with HIV and a history of nonmelanoma skin cancer had a higher risk for subsequent new primary squamous cell carcinoma, which was particularly associated with lower CD4 counts and higher viral loads, when compared with patients without HIV, according to recently published study results.

A survey of 551 U.S. parents with children younger than 18 years old found that 48% believed schools should provide sunscreen for students to use at school, according to results released by Deb Group.

The Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Bavencio (avelumab) as a monotherapy for treating adults with metastatic Merkel cell carcinoma, according a news release from Merck KGaA, Darmstadt, Germany, and Pfizer.

Patient age was a factor in regional lymph node positivity in clinically localized melanomas 0.5 mm to 10 mm, according to recently published study results in JAMA Dermatology.

Patients visiting EDs or urgent care clinics for sunburn treatment were associated with characteristics including psychiatric illness, alcohol use and homelessness, according to recently published study results in JAMA Dermatology.

The International Photodynamic Association announced that Pilar Acedo Nunez was awarded the 2017 IPA Early Investigator Award at the association’s world congress in Coimbra, Portugal.

CSA Medical announced it has received FDA (510K) clearance for the expansion of its truFreeze catheter liquid nitrogen spray cryotherapy system to include a third spray kit, which will be referred to as the Rapid AV Spray Kit.

The FDA’s approval of Tremfya for treating adults with moderate-to-severe plaque psoriasis was among the top read articles of the past week on Healio.com/Dermatology.